230 related articles for article (PubMed ID: 14735202)
21. Molecular and cellular biology of Wilms' tumour.
Maitland NJ; Brown KW; Poirier V; Shaw AP; Williams J
Anticancer Res; 1989; 9(5):1417-26. PubMed ID: 2556071
[TBL] [Abstract][Full Text] [Related]
22. SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers.
Dallol A; Da Silva NF; Viacava P; Minna JD; Bieche I; Maher ER; Latif F
Cancer Res; 2002 Oct; 62(20):5874-80. PubMed ID: 12384551
[TBL] [Abstract][Full Text] [Related]
23. Functional epigenomics approach to identify methylated candidate tumour suppressor genes in renal cell carcinoma.
Morris MR; Gentle D; Abdulrahman M; Clarke N; Brown M; Kishida T; Yao M; Teh BT; Latif F; Maher ER
Br J Cancer; 2008 Jan; 98(2):496-501. PubMed ID: 18195710
[TBL] [Abstract][Full Text] [Related]
24. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.
Dahl E; Wiesmann F; Woenckhaus M; Stoehr R; Wild PJ; Veeck J; Knüchel R; Klopocki E; Sauter G; Simon R; Wieland WF; Walter B; Denzinger S; Hartmann A; Hammerschmied CG
Oncogene; 2007 Aug; 26(38):5680-91. PubMed ID: 17353908
[TBL] [Abstract][Full Text] [Related]
25. Frequent epigenetic inactivation of the SLIT2 gene in gliomas.
Dallol A; Krex D; Hesson L; Eng C; Maher ER; Latif F
Oncogene; 2003 Jul; 22(29):4611-6. PubMed ID: 12881718
[TBL] [Abstract][Full Text] [Related]
26. Detection of Slit2 promoter hypermethylation in tissue and serum samples from breast cancer patients.
Kim GE; Lee KH; Choi YD; Lee JS; Lee JH; Nam JH; Choi C; Park MH; Yoon JH
Virchows Arch; 2011 Oct; 459(4):383-90. PubMed ID: 21894562
[TBL] [Abstract][Full Text] [Related]
27. Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling.
Lindsey JC; Lusher ME; Anderton JA; Bailey S; Gilbertson RJ; Pearson AD; Ellison DW; Clifford SC
Carcinogenesis; 2004 May; 25(5):661-8. PubMed ID: 14688019
[TBL] [Abstract][Full Text] [Related]
28. Methylation analysis of the glypican 3 gene in embryonal tumours.
Boily G; Saikali Z; Sinnett D
Br J Cancer; 2004 Apr; 90(8):1606-11. PubMed ID: 15083193
[TBL] [Abstract][Full Text] [Related]
29. Frequent SLIT2 promoter methylation in the serum of patients with ovarian cancer.
Dong R; Yu J; Pu H; Zhang Z; Xu X
J Int Med Res; 2012; 40(2):681-6. PubMed ID: 22613430
[TBL] [Abstract][Full Text] [Related]
30. Tumour specific promoter region methylation of the human homologue of the Drosophila Roundabout gene DUTT1 (ROBO1) in human cancers.
Dallol A; Forgacs E; Martinez A; Sekido Y; Walker R; Kishida T; Rabbitts P; Maher ER; Minna JD; Latif F
Oncogene; 2002 May; 21(19):3020-8. PubMed ID: 12082532
[TBL] [Abstract][Full Text] [Related]
31. Wilms' tumours: about tumour suppressor genes, an oncogene and a chameleon gene.
Huff V
Nat Rev Cancer; 2011 Feb; 11(2):111-21. PubMed ID: 21248786
[TBL] [Abstract][Full Text] [Related]
32. Multigene methylation analysis of conventional renal cell carcinoma.
Onay H; Pehlivan S; Koyuncuoglu M; Kirkali Z; Ozkinay F
Urol Int; 2009; 83(1):107-12. PubMed ID: 19641369
[TBL] [Abstract][Full Text] [Related]
33. Role of the WT1 gene in Wilms' tumour.
Haber DA; Housman DE
Cancer Surv; 1992; 12():105-17. PubMed ID: 1322241
[TBL] [Abstract][Full Text] [Related]
34. Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour.
Park S; Bernard A; Bove KE; Sens DA; Hazen-Martin DJ; Garvin AJ; Haber DA
Nat Genet; 1993 Dec; 5(4):363-7. PubMed ID: 8298644
[TBL] [Abstract][Full Text] [Related]
35. Methylation changes in promoter and enhancer regions of the WT1 gene in Wilms' tumours.
Mares J; Kríz V; Weinhäusel A; Vodicková S; Kodet R; Haas OA; Sedlácek Z; Goetz P
Cancer Lett; 2001 May; 166(2):165-71. PubMed ID: 11311489
[TBL] [Abstract][Full Text] [Related]
36. Molecular analysis of E-cadherin and cadherin-11 in Wilms' tumours.
Schulz S; Becker KF; Braungart E; Reichmuth C; Klamt B; Becker I; Atkinson M; Gessler M; Höfler H
J Pathol; 2000 Jun; 191(2):162-9. PubMed ID: 10861576
[TBL] [Abstract][Full Text] [Related]
37. SLIT2 axon guidance molecule is frequently inactivated in colorectal cancer and suppresses growth of colorectal carcinoma cells.
Dallol A; Morton D; Maher ER; Latif F
Cancer Res; 2003 Mar; 63(5):1054-8. PubMed ID: 12615722
[TBL] [Abstract][Full Text] [Related]
38. Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines.
Harada K; Toyooka S; Maitra A; Maruyama R; Toyooka KO; Timmons CF; Tomlinson GE; Mastrangelo D; Hay RJ; Minna JD; Gazdar AF
Oncogene; 2002 Jun; 21(27):4345-9. PubMed ID: 12082624
[TBL] [Abstract][Full Text] [Related]
39. Silencing of tumor suppressor genes RASSF1A, SLIT2, and WIF1 by promoter hypermethylation in hereditary breast cancer.
Alvarez C; Tapia T; Cornejo V; Fernandez W; Muñoz A; Camus M; Alvarez M; Devoto L; Carvallo P
Mol Carcinog; 2013 Jun; 52(6):475-87. PubMed ID: 22315090
[TBL] [Abstract][Full Text] [Related]
40. Hypermethylation of the RASSF1A tumor suppressor gene in Japanese clear cell renal cell carcinoma.
Tokinaga K; Okuda H; Nomura A; Ashida S; Furihata M; Shuin T
Oncol Rep; 2004 Oct; 12(4):805-10. PubMed ID: 15375503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
